| Financial Year |
March 31 2023 |
| Monetary Funds |
3,397,266.61 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
143,135,759.70 |
| Advances to Suppliers |
4,750,399.33 |
| Other Receivables |
3,258,321.04 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
20,302,208.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
68,997,406.09 |
| Other Current Assets |
19,602,672.61 |
| Total Current Assets |
265,432,061.92 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,959,381.01 |
| Investment Properties |
-- |
| Fixed Assetes |
84,920,165.62 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,695,658.73 |
| R&D expenses |
-- |
| Goodwill |
19,568,354.57 |
| Long-Term Deferred and Prepaid Expenses |
511,784.72 |
| Deferred Income Tax Assets |
61,641,980.51 |
| Other Non-Current Assets |
12,470,077.64 |
| Sub-Total of Non-Current Assets |
192,068,074.55 |
| Total Assets |
457,500,136.47 |
| Short-Term Loans |
91,952,939.09 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
95,929,803.16 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
23,037,544.20 |
| Taxes Payable |
8,275,508.36 |
| Interest Payable |
1,337,817.69 |
| Dividend Payable |
365,570.17 |
| Other payables |
86,835,971.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
17,941,962.82 |
| Other Current Liabilities |
95,714,213.68 |
| Sub-Total of Current Liabilities |
422,246,861.54 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,586,151.85 |
| Total Liabilities |
423,833,013.39 |
| Paid-In Capital(Or Share Stock) |
298,258,899.00 |
| Capital Surplus |
785,501,343.40 |
| Surplus Reserve |
23,301,754.84 |
| LESS:Treasury Stock |
17,400,044.00 |
| Undistributed Profits |
-1,055,966,484.51 |
| Minority Stockholder's Interest |
-28,345.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
33,695,468.73 |
| Owner's Equity（Stockholder's Equity） |
33,667,123.08 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
457,500,136.47 |
